Literature DB >> 11903319

Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.

B M Pannier1, A P Guerin, S J Marchais, G M London.   

Abstract

1. In arterial hypertension, aortic wave reflections contribute to determining central systolic and pulse pressures. The present study assessed the central pressure alterations at the level of the common carotid artery following 1 month treatment with perindopril or atenolol and investigated during the 8 h following drug intake. 2. Twenty patients suffering from permanent hypertension were included after a 4 week run-in placebo period in a double-blind, randomized cross-over study comparing the angiotensin-converting enzyme (ACE) inhibitor perindopril with the beta-blocker atenolol during a 4 week treatment period. 3. Before and during the 8 h after drug intake, serial measurements included brachial artery systolic and diastolic blood pressures (SBP and DBP, respectively; mercury sphygmomanometer), carotid artery SBP and pulse pressure (PP; applanation tonometry), aortic pulse wave velocity (Complior; Colson, Les Lilas, France) and arterial wave reflections from the aorta (applanation tonometry; Sphygmocor; PWV Medical, Sydney, NSW, Australia). 4. Both treatments decreased brachial and carotid artery SBP, DBP and PP. Heart rate and pulse wave velocity decreased following atenolol (P < 0.001). Pulse wave velocity was reduced slightly following perindopril (NS). Arterial wave reflections were significantly (P < 0.001) decreased with perindopril in comparison with atenolol, but this effect on wave reflections was not associated with a larger decrease in carotid artery PP. 5. Thus, during chronic treatment, ACE inhibition and selective beta1-adrenoceptor blockade resulted in a similar decrease in brachial and carotid artery PP, but only atenolol reduced heart rate. Aortic pulse wave velocity was reduced with both drugs, but atenolol appeared more effective in improving aortic stiffness. Arterial wave reflections were decreased only following perindopril. 6. Central pulse pressure was improved following 1 month treatment with an ACE inhibitor or beta-adrenoceptor blockade following a decrease in arterial wave reflections with perindopril and a higher decrease in regional aortic stiffness with atenolol.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11903319     DOI: 10.1046/j.1440-1681.2001.03570.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  15 in total

Review 1.  Better management of cardiovascular diseases by pulse wave velocity: combining clinical practice with clinical research using evidence-based medicine.

Authors:  Ali R Khoshdel; Shane L Carney; Balakrishnan R Nair; Alastair Gillies
Journal:  Clin Med Res       Date:  2007-03

2.  Pulse wave analysis and cardiac autonomic neuropathy in type 1 diabetes: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  Aaron M Secrest; Sara L Marshall; Rachel G Miller; Catherine T Prince; Trevor J Orchard
Journal:  Diabetes Technol Ther       Date:  2011-08-05       Impact factor: 6.118

3.  Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series).

Authors:  Wei Tan; Krishna Madhavan; Kendall S Hunter; Daewon Park; Kurt R Stenmark
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

4.  Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-17       Impact factor: 8.237

5.  Acute β-adrenergic blockade increases aortic wave reflection in young men and women: differing mechanisms between sexes.

Authors:  Darren P Casey; Timothy B Curry; Michael J Joyner; Nisha Charkoudian; Emma C Hart
Journal:  Hypertension       Date:  2011-11-21       Impact factor: 10.190

6.  Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia--the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT).

Authors:  S Theilade; B Claggett; T W Hansen; H Skali; E F Lewis; S D Solomon; H-H Parving; M Pfeffer; J J McMurray; P Rossing
Journal:  J Hum Hypertens       Date:  2015-03-26       Impact factor: 3.012

7.  Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetes.

Authors:  Catherine T Prince; Aaron M Secrest; Rachel H Mackey; Vincent C Arena; Lawrence A Kingsley; Trevor J Orchard
Journal:  Atherosclerosis       Date:  2010-09-15       Impact factor: 5.162

Review 8.  Trials in isolated systolic hypertension: an update.

Authors:  Bernard Waeber
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

Review 9.  Trials in isolated systolic hypertension: an update.

Authors:  Bernard Waeber
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

10.  Aortic elastic properties : effects of carvedilol versus nebivolol.

Authors:  M R Sayin; M Aydin; S M Dogan; T Karabag; M A Cetiner; Z Aktop
Journal:  Herz       Date:  2012-12-23       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.